MedTrace Logo

Radiation Pneumonitis After SBRT for NSCLC

NCT02428049 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 105

Last updated 2023-01-20

No results posted yet for this study

Summary

Aims:

1. Evaluate changes in lung function before and after radiotherapy for patients with NSCLC in stage I-III receiving curatively intended radiotherapy
2. To assess the predictive value of pulmonary function tests for the development of radiation pneumonitis after curative radiotherapy
3. To assess biomarkers in blood samples before, during, and after radiotherapy and correlate to the development of radiation pneumonitis
4. Investigate survival

Conditions

Interventions

RADIATION

Stereotactic or conventional radiotherapy and chemotherapy in curative intent

Sponsors & Collaborators

  • Norwegian Radium Hospital

    collaborator OTHER

  • Oslo University Hospital

    collaborator OTHER

  • Sykehuset i Vestfold HF

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2018-12-31
Completion
2025-12-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02428049 on ClinicalTrials.gov